These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39275851)

  • 1. Prognostic Value of IGFBP6 in Breast Cancer: Focus on Glucometabolism.
    Lu H; Yu X; Xu Z; Deng J; Zhang MJ; Zhang Y; Sun S
    Technol Cancer Res Treat; 2024; 23():15330338241271998. PubMed ID: 39275851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker.
    Chen Q; Qin S; Liu Y; Hong M; Qian CN; Keller ET; Zhang J; Lu Y
    Oncotarget; 2016 Oct; 7(42):68140-68150. PubMed ID: 27623076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the prognostic value of glutathione S-transferases Mu family members in breast cancer.
    Gohari N; Abbasi E; Akrami H
    Cell Biol Int; 2024 Sep; 48(9):1313-1325. PubMed ID: 38922769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IGFBP6 Protein in the Regulation of Epithelial-Mesenchymal Transition Genes.
    Nikulin SV; Raigorodskaya MP; Poloznikov AA; Zakharova GS; Schumacher U; Wicklein D; Stürken C; Riecken K; Fomicheva KA; Alekseev BY; Shkurnikov MY
    Bull Exp Biol Med; 2018 Mar; 164(5):650-654. PubMed ID: 29577195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.
    Oliva CR; Halloran B; Hjelmeland AB; Vazquez A; Bailey SM; Sarkaria JN; Griguer CE
    Cell Commun Signal; 2018 Sep; 16(1):61. PubMed ID: 30231881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
    Liu D
    Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer.
    Fan X; Qi A; Zhang M; Jia Y; Li S; Han D; Liu Y
    Diagn Pathol; 2024 Aug; 19(1):113. PubMed ID: 39175074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics and prognostic value of IGFBP6 in glioma.
    Zong Z; Xin L; Tang X; Guo H
    Neurol Res; 2022 Feb; 44(2):113-120. PubMed ID: 34396926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
    Ren H; Hu D; Mao Y; Su X
    Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
    Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
    Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCGA Database-Based Screening of Tumor Microenvironment Immunomodulators Related to Bladder Cancer Prognosis.
    Ye JN; Gan MP; Wu XL; Dong Z; Mai HH
    Ann Clin Lab Sci; 2024 May; 54(3):299-312. PubMed ID: 39048164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP6 Regulates Cell Apoptosis and Migration in Glioma.
    Bei Y; Huang Q; Shen J; Shi J; Shen C; Xu P; Chang H; Xia X; Xu L; Ji B; Chen J
    Cell Mol Neurobiol; 2017 Jul; 37(5):889-898. PubMed ID: 27650075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.
    Liu L; Yang J; Wang C
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.